AstraZeneca (NASDAQ:AZN) reported quarterly earnings of $2.58 per share which beat the analyst consensus estimate of $2.51 by 2.79 percent. This is a 106.4 percent increase over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $15.288 billion which beat the analyst consensus estimate of $14.939 billion by 2.33 percent. This is a 12.51 percent increase over sales of $13.588 billion the same period last year.